# DESCRIPTION

## FIELD OF THE INVENTION

- relate to breast cancer classification

## BACKGROUND OF THE INVENTION

- motivate breast cancer research

## SUMMARY OF THE INVENTION

- introduce PAM50 classification model

## DETAILED DESCRIPTION OF THE INVENTION

### Overview

- motivate breast cancer treatment
- introduce breast cancer subtypes
- describe limitations of current classification methods

### Clinical Variables

- describe clinical variables for breast cancer prognosis

### Sample Source

- describe biological sample sources for breast cancer diagnosis

### Expression Profiling

- introduce pattern recognition algorithms for breast cancer classification
- describe supervised algorithm for PAM50 classification model

### Detection of Intrinsic Gene Expression

- define detection of intrinsic gene expression
- describe methods for detecting expression of intrinsic genes
- introduce RNA isolation and purification
- describe hybridization and amplification assays
- detail quantitative PCR and microarray analysis
- discuss application of detection methods

### Data Processing

- introduce data preprocessing
- describe scaling and normalization methods
- discuss translation and weighting techniques

### Calculation of Risk of Relapse

- introduce risk of relapse model
- describe calculation of risk score using intrinsic subtype distances and clinical variables

### Prediction of Response to Therapy

- motivate breast cancer treatment strategies
- describe PAM50 model for risk stratification
- predict response to therapy using PAM50 risk score

### Kits

- describe kit components for breast cancer classification
- provide database for molecular signatures and expression profiles

## EXPERIMENTAL

### Example 1

- describe patient cohorts
- extract nucleic acid
- perform reverse transcription and real-time quantitative PCR
- analyze microarray data
- preprocess microarray data
- identify prototypical intrinsic subtype samples and genes
- reduce gene set using prototype samples and qRT-PCR
- predict sample subtypes
- assess prognosis using clinical and molecular subtype data
- develop risk models with clinical and molecular data

## Example 2

### Introduction and Background Data

- introduce PAM50-based intrinsic subtype classifier

### Summary

- summarize PAM50-based intrinsic subtype classifier

### Methodology:

- describe methodology of PAM50-based intrinsic subtype classifier

### Results:

- present results of PAM50-based intrinsic subtype classifier

## Example 3

- describe risk of relapse analysis

### Prognostic and Predictive Models Using Clinical and Molecular Subtype Data:

- describe prognostic and predictive models

### Comparison of Relapse Prediction Models

- compare relapse prediction models

### Risk of Relapse Models for Prognosis in Node-Negative Breast Cancer

- describe risk of relapse models

### Subtypes and Prediction of Response to Neoadjuvant T/FAC Treatment

- describe subtypes and prediction of response to neoadjuvant T/FAC treatment

## Example 4

- introduce study on PAM50 classifier in estrogen receptor positive breast cancer patients

### Patients:

- describe patient cohort and selection criteria

### RNA Preparation:

- outline RNA extraction and quality control process

### Assignment of Biological Subtype to Clinical Samples:

- describe construction of gene expression centroids and assignment of intrinsic subtypes

### Relation of PAM50 Subtype to Clinical Outcome:

- perform Kaplan-Meier and Cox regression analyses to assess prognostic significance of PAM50 subtype

### Relation of Risk-Of-Relapse (ROR) Score to Clinical Outcome:

- describe calculation and validation of ROR score and its prognostic significance

### Results

- summarize patient characteristics and PAM50 subtype assignments
- present Kaplan-Meier analysis of PAM50 subtype and clinical outcome
- describe multivariate Cox regression analysis of PAM50 subtype and clinical outcome
- present results of ROR score analysis
- compare PAM50 subtype and ROR score with clinical risk classifiers

### Discussion

- discuss implications of study findings for breast cancer treatment and prognosis
- compare PAM50 qPCR assay with other gene expression profiling methods
- highlight advantages of PAM50 qPCR assay in breast cancer prognosis and treatment

